Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Market Capitalization (2010 - 2026)

Nomad Power Solutions (NMAD) posted Market Capitalization of $114.4 million for Q2 2026, up 410.3% on a QoQ basis from $22.4 million in Q4 2025, and up 4520.84% year-over-year from $2.5 million in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Market Capitalization (2010 - 2026) Analysis & Trends

Nomad Power Solutions has reported Market Capitalization for 17 years, with the latest figure at $114.4 million in Q2 2026.

  • On a quarterly basis, Market Capitalization rose 4520.84% year-over-year to $114.4 million in Q2 2026; TTM through Jun 2026 was $114.4 million, a 4520.84% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, up 93.6% from the prior year.
  • Market Capitalization was $114.4 million for Q2 2026 at Nomad Power Solutions, up from $22.4 million in the prior quarter.
  • The five-year high for Market Capitalization was $169.1 million in Q1 2022, with the low at $2.5 million in Q2 2025.
  • Average Market Capitalization over 5 years is $48.4 million, with a median of $9.8 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: Market Capitalization slumped 94.5% in 2024, then jumped 4520.84% in 2026.
  • Over 5 years, Market Capitalization stood at $84.9 million in 2022, then sank by 93.77% to $5.3 million in 2023, then declined by 13.62% to $4.6 million in 2024, then jumped by 390.96% to $22.4 million in 2025, then jumped by 410.3% to $114.4 million in 2026.
  • The last three Market Capitalization figures came in at $114.4 million (Q2 2026), $22.4 million (Q4 2025), and $28.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114.40 Mn
Dec 31, 2025 22.42 Mn
Sep 30, 2025 28.69 Mn
Jun 30, 2025 2.48 Mn
Mar 31, 2025 3.25 Mn
Dec 31, 2024 4.57 Mn
Sep 30, 2024 4.21 Mn
Jun 30, 2024 5.33 Mn
Mar 31, 2024 7.60 Mn
Dec 31, 2023 5.29 Mn
Sep 30, 2023 5.51 Mn
Jun 30, 2023 9.80 Mn
Mar 31, 2023 138.27 Mn
Dec 31, 2022 84.90 Mn
Sep 30, 2022 93.22 Mn
Jun 30, 2022 123.18 Mn
Mar 31, 2022 169.08 Mn
Dec 31, 2021 163.58 Mn
Sep 30, 2021 285.93 Mn
Jun 30, 2021 414.00 Mn